Roivant Sciences Ltd. (ROIV) Misses Q2 EPS by 11c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q2 EPS of ($0.40), $0.11 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $37.1 million versus the consensus estimate of $29.11 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
• Citi raises Broadcom price target to $515 amid AI outlook
• Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance